GLOBUS MEDICAL INC - CL A (GMED)

Historical Portfolio Holders from Q1 2014 to Q3 2024

All holders as of September 30, 2024
Q3 2024
Type / Class
Equity / CL A
Shares, excl. options Q3 2024
106M
Holdings value Q3 2024
$7.6B
Value change Q3 2024
-$457M
Grand Portfolio weight change Q3 2024
-0.001%
Number of holders
440
Number of buys Q3 2024
190
Number of sells Q3 2024
-224
Average buys Q3 2024 %
+0.001%
Average sells Q3 2024 %
-0.003%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q3 106M $7.6B -$457M $71.54 442
2024 Q2 113M $7.72B +$131M $68.49 443
2024 Q1 111M $5.98B +$238M $53.64 433
2023 Q4 107M $5.68B -$105M $53.29 402
2023 Q3 108M $5.38B +$1.31B $49.65 421
2023 Q2 81.3M $4.84B +$408M $59.54 375
2023 Q1 74.6M $4.22B -$150M $56.64 381
2022 Q4 75.8M $5.63B +$87.5M $74.27 380
2022 Q3 74.3M $4.43B +$96.3M $59.57 353
2022 Q2 72.2M $4.05B +$130M $56.14 348
2022 Q1 69.3M $5.11B +$80.9M $73.78 363
2021 Q4 68.1M $4.92B +$7.79M $72.20 367
2021 Q3 67.4M $5.17B -$69.3M $76.62 379
2021 Q2 67.8M $5.25B +$27.1M $77.53 353
2021 Q1 67.5M $4.16B +$53.3M $61.67 338
2020 Q4 66.6M $4.34B +$138M $65.22 344
2020 Q3 64.4M $3.19B -$115M $49.52 335
2020 Q2 66.7M $3.18B -$236M $47.71 311
2020 Q1 71.7M $3.05B +$120M $42.53 266
2019 Q4 67.2M $3.96B -$29.1M $58.88 303
2019 Q3 68M $3.48B +$22.9M $51.12 265
2019 Q2 67.9M $2.87B +$68.1M $42.30 256
2019 Q1 66.7M $3.29B -$66.8M $49.41 264
2018 Q4 68.2M $2.95B +$98.5M $43.28 303
2018 Q3 65.5M $3.72B +$107M $56.76 311
2018 Q2 63.6M $3.21B +$91.2M $50.46 289
2018 Q1 62M $3.08B -$55.5M $49.82 277
2017 Q4 63.3M $2.6B -$178M $41.10 255
2017 Q3 67.6M $2.01B +$104M $29.72 248
2017 Q2 63.9M $2.11B -$10.1M $33.15 241
2017 Q1 66.3M $1.96B +$212M $29.62 241
2016 Q4 66.4M $1.65B +$49.8M $24.81 205
2016 Q3 65.1M $1.47B -$90M $22.57 192
2016 Q2 68.9M $1.64B +$5.9M $23.83 203
2016 Q1 69.5M $1.65B +$49M $23.75 201
2015 Q4 68.2M $1.86B +$18M $27.82 187
2015 Q3 66.6M $1.38B +$90.2M $20.66 179
2015 Q2 62.3M $1.6B -$1.44M $25.67 174
2015 Q1 62.7M $1.58B +$33.7M $25.24 179
2014 Q4 61.3M $1.46B +$92.1M $23.77 184
2014 Q3 57.2M $1.12B +$35.1M $19.67 163
2014 Q2 54.4M $1.3B +$4.07M $23.92 174
2014 Q1 53.2M $1.41B +$61.4M $26.59 156